Annual pelvic exams are still an important tool in the overall assessment of a woman’s health, say physicians in the Cedars-Sinai Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute.
Recently, the American College of Physicians (ACP) recommended that annual pelvic exams be eliminated for average-risk, asymptomatic women. The ACP speculated false-positive results could cause potential harm.
Cedars-Sinai women’s cancer experts disagree. “We continue to support the position of the American Board of Obstetrics and Gynecology (ABOG) and their recommendation for annual pelvic exams for women over 21 years of age,” said Beth Y. Karlan, MD, Director of the Cedars-Sinai Women’s Cancer Program.
Women should visit their healthcare providers yearly. “The decision of whether or not to conduct a pelvic exam should be made on an individual basis between the physician and the patient,” added Dr. Karlan.
BJ Rimel, MD, gynecologic oncologist in the Women’s Cancer Program, explains more about the procedure, which her team considers an “important adjunct” to regular physicals. While the pelvic exam has its limitations, says Dr. Rimel, “that doesn’t preclude the possibility or probability that some patients will distinctly benefit from this non-invasive exam.”
If you were watching the news or following social media last week, you may have seen this headline: Women with BRCA1 mutations should remove ovaries by age 35. Many major media outlets reported this story, and it is based on study results that appeared in the February 24 issue of the Journal of Clinical Oncology.
The Cedars-Sinai Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute and our Gilda Radner Hereditary Cancer Program participated in this study and the analysis of the results, and I am an author on the report, entitled Impact of Oophorectomy on Cancer Incidence and Mortality in Women with a BRCA1 or BRCA2 Mutation.The research is based on data from an international registry of almost 6,000 BRCA carriers, some with cancer and some without. Our goal was to estimate the benefit ofrisk-reducing salpingo-oophorectomy surgery (removing the ovaries and fallopian tubes) in patients who have a BRCA1 or BRCA2 mutation. Read On
Diane Park, Clinical Research Coordinator for the Women’s Cancer Program, helps a Run for Her participant enroll in the Research for Her registry at the 9th annual Run for Her in Pan Pacific Park.
Recently, the Health Improvement Institute recognized Cedars-Sinai—and the Research for Her initiative—with the Award of Excellence in Human Research Protection for Best Practice for developing an online consent process. This is a great honor for all those involved with the Research for Her national cancer research registry, which is administered by the Cedars-Sinai’s Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute. Read On
This wonderful letter came to us from Pilar Wolfe, a proud member of Team Mora and participant at the 9th annual Run for Her® 5K Run and Friendship Walk in Los Angeles:
I just wanted to share a story about how important Run for Her is in our lives. Five years ago, my incredibly courageous sister-in-law, Norma Mora, introduced us to Run for Her in the fight against ovarian cancer, and Team Mora was born! Since then, we have faithfully supported this wonderful cause in the hopes of finding a cure. And now, more than ever, we stand strong in this fight—honoring the loving memory of Norma. Read On
One of the teams you’ll see at the 9th annual Run for Her® is Cedars-Sinai’s 3 North. Here is their story:
Members of 3 North’s Run for Her team
By the time they got to the starting line for their first Run for Her® 5K Run and Friendship Walk last year, leaders of the 3 North team had already surprised themselves with their performance. Their team — officially named “CSMC 3 North Mother/Baby” — signed up more than 100 members, placing 3 North among the event’s five largest teams, and it raised more than $5,000.
At this year’s run on Nov. 10, they hope to exceed 2012′s performance, fueled by new motivation. They will be running for Danyel Hitchman, a 26-year-old ovarian cancer patient who stole their hearts during her stay in their maternity unit. Read On